Atrial Fibrillation Clinical Trial
Official title:
General Anesthesia With Endotracheal Tube Versus Laryngeal Mask Airway in Patients Undergoing Catheter Ablation for Atrial Fibrillation, a Non-inferiority Trial
In recent years it has been shown that catheter ablation of symptomatic atrial fibrillation
(PAF) is superior to antiarrhythmic drug therapy with regards to effectiveness and clinical
outcomes. Atrial fibrillation is the most common cardiac arrhythmia, with high rates of
concomitant heart failure, stroke and mortality. During an ablation procedure, a patient can
be managed with intravenous sedation or General Anesthesia (GA). Within this setting, General
anesthesia is associated with improved procedure time and cure rate compared to sedation.
Airway management during GA can be achieved through a laryngeal mask airway (LMA) or an
endotracheal tube (ETT). The use of LMA compared to ETT has been shown in different surgical
populations to decrease procedure and recovery time, improve hemodynamic stability and reduce
anesthetic requirements. It has also shown to decrease airway complications, and
postoperative nausea/vomiting which are important factors that affect overall patient
satisfaction.
Although general anesthesia in electrophysiology procedures is associated with a higher cure
rate, there have been reports of increased airway trauma.Additionally, it is believed that
volatile anesthetics may be associated with increased ventricular action potential duration
as well as prolonged QT interval. The increased usage of opioids during general anesthesia is
also thought to interfere with electrophysiology studies by affecting vagal tone.
At Virginia Commonwealth University (VCU) Health system, Anesthesiologists have been
successfully using LMA (General Anesthesia) for ablation in PAF in eligible patients for over
five years. The investigators plan to perform a retrospective review of all patients who
underwent catheter ablation of PAF at Virginia Commonwealth University Health System from
January 2014 - December 2015. The primary endpoint evaluated will be procedure time. Other
data collected will include demographics, cardiac history, type of anesthesia, amount of
intra-procedure opioids, time to discharge from post anesthesia care unit (PACU), total
length of hospital stay, intra-procedure hemodynamics, intra-procedure
ionotrope/chronotrope/pressor requirements. and atrial fibrillation recurrence at a 3 month
follow-up.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |